S-amlodipine in Essential HypertensIon and Assessment of Blood Pressure Targets Achievement

Clinical trial NCT06130124 · UNKNOWN

Trial details

NCT number: NCT06130124
Sponsor: Hanlim Pharm. Co., Ltd.
Status: UNKNOWN
Study type: OBSERVATIONAL

Essential Hypertension

Start date: 2023-02-22
Primary completion: 2025-04-22
Enrollment: 5000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.